# Methylprednisolone Adjunctive to Endovascular Thrombectomy for Stroke

Study · id `cardio:ct-nct06360458` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06360458](<https://clinicaltrials.gov/study/NCT06360458>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06360458

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 928 participants.

## Technical summary

Registry record NCT06360458. Randomized; quadruple masking; primary purpose treatment. Start 2024-08-01 (actual); primary completion 2025-09-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 928 participants (enrolled count; ClinicalTrials.gov record NCT06360458, source copy `cardio:ctgov-nct06360458-2025-12-03`, retrieved 2026-10-26)
- Started: 2024-08-01 (actual) (ClinicalTrials.gov record NCT06360458, source copy `cardio:ctgov-nct06360458-2025-12-03`, retrieved 2026-10-26)
- Primary completion: 2025-09-30 (actual) (ClinicalTrials.gov record NCT06360458, source copy `cardio:ctgov-nct06360458-2025-12-03`, retrieved 2026-10-26)
- Completion: 2030-06-30 (anticipated) (ClinicalTrials.gov record NCT06360458, source copy `cardio:ctgov-nct06360458-2025-12-03`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06360458, source copy `cardio:ctgov-nct06360458-2025-12-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06360458-2025-12-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Methylprednisolone Adjunctive to Endovascular Thrombectomy for Stroke
- Acronym: MIRACLE
- Condition: Acute Ischemic Stroke
- Condition: Large Infarct Core
- Intervention (Drug): Methylprednisolone sodium succinate
- Intervention (Drug): Placebo
- Lead sponsor: Wan-Jin Chen
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: d38fe7fed1f4a14e677beeca1c42d154cb5f2da898066f41498c2531cfc4a98b
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
